Saturday, July 11, 2026

Drug profile · INN

votumumab

votumumab (HUMASPECT) is a diagnostic agent.

EMA: withdrawn Various (V09) V09IX
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — votumumab
Class
Various (V09)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

votumumab (HUMASPECT) is a diagnostic agent.

Key facts

INN votumumab
Brand HUMASPECT
Mechanism Diagnostic agent
Therapeutic class Various (V09)
ATC code V09IX

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
EMA withdrawn

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is votumumab?

votumumab (HUMASPECT) is a diagnostic agent.

What is the brand name for votumumab?

HUMASPECT is a marketed brand name for votumumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.